Immatics (IMTX) Accumulated Expenses (2023 - 2025)

Immatics (IMTX) reported Accumulated Expenses of $21.5 million for Q4 2025, up 1175.73% on a YoY basis from $1.7 million in Q4 2024, and up 1175.73% sequentially from $1.7 million in Q4 2024.

Immatics (IMTX) Accumulated Expenses (2023 - 2025) Analysis & Trends

Immatics (IMTX) has 3 years of Accumulated Expenses data on file, last reported at $21.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 1175.73% year-over-year to $21.5 million; the trailing twelve-month figure through Dec 2025 stood at $21.5 million (up 1175.73% YoY), and the FY2025 full-year result was $20.9 million, up 1122.49% from the prior year.
  • Accumulated Expenses grew to $21.5 million in Q4 2025, from $1.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $21.5 million in Q4 2025 to a low of $1.7 million in Q4 2024.
  • A 3-year average of $14.0 million and a median of $18.9 million in 2023 frame the typical range for Accumulated Expenses.
  • Across the five-year window, Accumulated Expenses sank 91.06% in 2024 and surged 1175.73% in 2025, its largest moves.
  • Tracing IMTX's Accumulated Expenses over 3 years: stood at $18.9 million in 2023, then plunged by 91.06% to $1.7 million in 2024, then surged by 1175.73% to $21.5 million in 2025.
  • Business Quant data shows IMTX's Accumulated Expenses at $21.5 million in Q4 2025, $1.7 million in Q4 2024, and $18.9 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Immatics 1.11 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 21.53 Mn
Dec 31, 2024 1.69 Mn
Dec 31, 2023 18.87 Mn